Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial

Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial

Abstract Background Prophylactic anticoagulation with rivaroxaban significantly reduced the risk of cancer‐associated thrombosis during the intervention period in the CASSINI trial. Direct oral anticoagulants may increase the risk of gastrointestinal (GI) tract bleeding in patients with an in situ G...

Full description

Bibliographic Details
Main Authors: Jodi V. Mones, Michael B. Streiff, Alok A. Khorana, Gemma A. Bendheim, C. V. Damaraju, Peter Wildgoose, Paul Burton, Hanno Riess, Gerald A. Soff
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
cancer
gastric
gastroesophageal junction
prophylaxis
rivaroxaban
Online Access:https://doi.org/10.1002/rth2.12549

Internet

https://doi.org/10.1002/rth2.12549

Similar Items